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Hypohidrotic ectodermal dysplasia (HED) is a genetic disease characterized by abnormal hair, teeth, and sweat
gland development. Although most cases of HED display X-linked recessive inheritance, autosomal dominant and
autosomal recessive forms also exist. X-linked HED is caused by mutations in the EDA gene, and the autosomal
forms result from mutations in either the EDAR gene or the EDARADD gene. In this study, we identiﬁed compound
heterozygous mutations in the EDAR gene in a Japanese female patient with HED. On the maternal allele is a novel
splice donor site mutation of intron 2 leading to the generation of unstable transcripts with exon 2 skipping; on the
paternal allele is a novel R375H transition within the death domain of EDAR. Using expression studies in tissue
culture cells, we found that the R375H substitution in EDAR caused loss of its afﬁnity for EDARADD and reduced
activation of the downstream target NF-jB. Our ﬁndings indicate that both alleles of EDAR are non-functional in our
patient, resulting in the HED phenotype.
Key words: compound heterozygous mutations/death domain/EDAR gene/hypohidrotic ectodermal dysplasia
J Invest Dermatol 123:649 –655, 2004
Hypohidrotic ectodermal dysplasia (HED) is a congenital
disorder characterized by the absence or hypoplasia of hair,
teeth, and eccrine sweat glands. HED usually shows an X-
linked recessive inheritance pattern (MIM 305100), but a
minority of HED is inherited as an autosomal dominant (MIM
129490) or recessive trait (MIM 224900). A candidate gene
for X-linked HED, the EDA gene, was partially cloned on the
X chromosome (Kere et al, 1996), and its complete structure
was subsequently reported (Baye´s et al, 1998; Monreal et al,
1998). The EDA gene encodes various isoforms of a type II
transmembrane protein due to alternative splicing. Of these
variants, ectodysplasin-A1 (EDA-A1) is the longest form,
sharing the characteristic features of the tumor necrosis
factor (TNF) ligand superfamily (Baye´s et al, 1998). In 1999,
the EDAR gene, which is responsible for autosomal dom-
inant and recessive HED, was then cloned on chromosome
2q11–q13 (Monreal et al, 1999). The EDAR gene is com-
posed of 12 exons and encodes the EDA-A1 receptor,
EDAR (Yan et al, 2000). EDAR is a member of the TNF re-
ceptor (TNFR) superfamily, as it is a type I transmembrane
protein containing a cysteine-rich domain in the extracellu-
lar region as well as a potential death domain (DD) in its
intracellular region (Monreal et al, 1999). Receptors con-
taining a DD initiate intracellular signaling by interacting
with their adapter proteins (Hofmann, 1999). Recently, the
EDARADD gene encoding EDARADD, an adapter protein of
EDAR, has been identified (Headon et al, 2001; Yan et al,
2002). EDARADD also has a DD in its C-terminus. EDAR is
considered to function by associating with EDARADD via
their DD, leading to the downstream activation of NF-kB
(Headon et al, 2001; Yan et al, 2002). Furthermore, a ho-
mozygous missense mutation of the EDARADD gene has
been identified in a family with HED showing an autosomal
recessive trait (Headon et al, 2001).
To date, only five pathogenic mutations of HED have
been reported in the EDAR gene (Monreal et al, 1999). In
this study, we found unique compound heterozygous mu-
tations in the EDAR gene in a Japanese female patient af-
fected with HED. Both are novel mutations and one results
in amino acid substitution in the DD of EDAR. We further
investigated how this amino acid change influenced the
association between EDAR and EDARADD followed by the
activation of NF-kB.
Results
Identiﬁcation of two different mutations in the EDAR
gene Using the patient’s genomic DNA, we performed DNA
sequencing of all the exons and exon–intron boundaries of
the EDA, EDAR, and EDARADD genes. No mutations were
found in either the EDA or the EDARADD gene, whereas
two different mutations were identified in the EDAR gene of
the patient genomic DNA.
The first mutation was a heterozygous G ! A transition
at the first base pair of intron 2 of the EDAR gene (exon 2
IVSþ 1G ! A) (Fig 1a). Interestingly, we also sequenced the
exon 2—intron 2 boundary of her parents and her older
sister, and none had this mutation, although haplotype
analysis suggested maternal and paternal transmission of a
Abbreviations: DD, death domain; HED, hypohidrotic ectodermal
dysplasia
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chromosomal segment harboring the EDAR locus (Fig 1b).
Furthermore, allele-specific PCR was developed using ei-
ther a wild-type-specific or a mutation-specific forward
primer, and a common reverse primer. PCR with the wild-
type-specific primer amplified a fragment from the DNA of
the patient, her family members, and 100 control individu-
als, whereas the mutation-specific primer only generated
an amplified product from the patient’s DNA (Fig 1c). As no
single nucleotide polymorphisms were detected around the
exon 2—intron 2 boundary of the patient, we could not de-
termine whether this mutation had occurred in the paternal
or maternal allele at the genomic DNA level.
The second mutation was a heterozygous G ! A tran-
sition (1124G ! A) in exon 12 of the EDAR gene, resulting
in R375H substitution at the protein level (Fig 2a). This nuc-
leotide substitution destroyed the HhaI restriction enzyme
site. We, therefore, performed PCR using the EDAR exon
12-specific primers, and digested the amplified products
with this enzyme. The PCR product from the wild-type all-
ele, 263 bp in size, was digested to 158 and 105 bp frag-
ments. This analysis showed that not only the patient but
also her father had the 1124G ! A mutation heterogene-
ously, whereas her mother and her older sister, as well as
100 control individuals, had homozygous wild-type alleles
(Fig 2b). We confirmed that the father had this mutation by
direct sequencing.
The exon 2 IVSþ 1G ! A mutation resulted in exon 2
skipping of the EDAR transcripts In order to analyze how
the exon 2 IVSþ1G ! A transition influenced the splicing
of the EDAR gene, RT-PCR was performed using primers
located in the EDAR exons 1 and 3. Agarose gel elect-
rophoresis of the PCR products showed the presence of
two fragments (219 and 150 bp) in the patient, whereas a
single fragment (219 bp) was amplified in the control indi-
vidual (Fig 3a). Direct sequencing of these products proved
that the longer fragment was the transcript of the EDAR
gene generated by normal splicing (Fig 3b), and that the
shorter fragment was the abnormal EDAR transcript result-
ed from the skipping of exon 2 (69 bp long) (Fig 3c).
Stable EDAR transcripts were generated only from the
paternal allele To determine whether the exon 2 skipping
in the patient genome occurred from the paternal or ma-
ternal EDAR gene, we performed RT-PCR using primers
located in the EDAR exons 1 and 12. The PCR product
covered the entire coding region of the EDAR transcripts.
We speculated that two size variants would have been am-
plified from the patient’s cDNA due to the exon skipping.
Agarose gel electrophoresis, however, showed that only
a single fragment, about 1400 bp in size, was detected
(Fig 3d). Direct sequencing of the amplified product demon-
strated that this was the EDAR transcript generated by
Figure 1
Heterozygous exon 2 IVSþ1G ! A mutation in the patient’s EDAR
gene. (a) A heterozygous mutation of the splice donor site of intron 2
(exon 2 IVSþ 1G ! A) was identified in the patient’s EDAR gene. (b)
Haplotype analysis proved maternal and paternal transmission of a
chromosomal segment harboring the EDAR locus. The product size of
PCR for each micro-satellite marker is indicated. (c) Allele-specific PCR
showed that the exon 2 IVSþ 1G ! A mutation exists only in the pa-
tient’s EDAR gene. MWM, molecular weight markers. GenBank acces-
sion numbers for the EDAR exons 1–12: AF130989-AF130996.
Figure2
Heterozygous 1124G ! A mutation in the patient’s EDAR gene. (a)
A heterozygous 1124G ! A mutation, which resulted in R375H tran-
sition, was identified in exon 12 of the patient’s EDAR gene. (b) HhaI
restriction enzyme analysis showed that 1124G ! A mutation was in-
herited from the patient’s unaffected father.
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normal splicing and those with exon skipping were not de-
tected at all (Fig 3e). Furthermore, the base pair at position
1124 of this product was ‘‘A’’, which corresponded to the
transcripts from the paternal allele (Fig 3e). We then per-
formed RT-PCR between exons 1 and 4 as well as between
exons 11 and 12. Interestingly, the shorter product due to
the absence of exon 2 was not amplified even by exons 1–4
PCR (Fig 3d). In addition, direct sequence corresponding to
the cDNA of exons 11 and 12 showed only monoallelic
1124A (paternal) transcripts just as in exons 1–12. These
data indicate that the exon 2 IVSþ 1 G ! A mutation which
induced exon 2 skipping was on the maternal allele, and
most of the maternal EDAR transcripts could not be de-
tected in the patient whereas the paternal EDAR transcripts
were successfully amplified (Fig 3e). Therefore, we con-
cluded that stable EDAR transcripts were generated only
from the paternal allele, and thus, only the paternal EDAR
proteins with R375H substitution were synthesized in the
patient.
Mutant EDAR-R375H has lost the afﬁnity to EDARADD
and reduced the activation of NF-jB EDAR has been
shown to bind to EDARADD via its C-terminal DD (amino
acid: 356-431) (Headon et al, 2001; Yan et al, 2002). In order
to analyze whether the R375H transition of EDAR changed
its affinity to EDARADD, we investigated the interaction be-
tween EDAR and EDARADD by immunoprecipitation using
N-terminal-tagged proteins expressed in cultured HEK293T
cells. As shown in Fig 4, wild-type EDARIC (375R) suc-
cessfully co-precipitated with EDARADD, whereas mutant
EDARIC (375H) completely lacks this interaction. As the
next step, we examined how the R375H mutation of EDAR
affected the downstream activation of NF-kB with the Dual-
Luciferase Assay System (Promega, Madison, Wisconsin).
In this assay, the pRL-TK vector (Promega) was cot-
ransfected as an internal control reporter. We used HE-
K293T cells because HEK293T cell lines expressed
endogenous EDARADD in the previous study (Headon
et al, 2001). Before the transfection of vectors, we recon-
Figure 3
RT-PCR analysis of the EDAR transcripts. (a) RT-PCR between the
EDAR exons 1 and 3 amplified two size variants in the patient. GAPDH
mRNA, 597 bp in size, was amplified as a control. (b) Sequence data of
the 219 bp fragment in a corresponded to the EDAR transcripts gen-
erated by normal splicing. (c) Sequencing of the 150 bp fragment in a
revealed aberrant EDAR transcripts with exon 2 skipping, which must
have originated from the exon 2 IVSþ 1G ! A mutant allele. (d) RT-
PCR, including downstream of the EDAR exon 4, amplified a single
fragment whose product sizes were identical between the patient and a
control individual. (e) The sequence data of the patient’s EDAR exons
1–12 PCR product in d corresponded to the paternal EDAR transcripts
generated by normal splicing. A schematic summary of the RT-PCR
analysis is also shown below. Note that most of the maternal EDAR
mRNA, except for its 50-end, could not be detected in this study. Gen-
Bank accession number for the EDAR cDNA: AF130988.
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firmed the expression of endogenous EDARADD mRNA
in HEK293T cells by RT-PCR (data not shown). As shown in
Fig 5, R375H mutant EDAR markedly reduced the activation
of NF-kB compared to wild-type EDAR.
Discussion
In this study, we identified 2 compound heterozygous mu-
tations, exon 2 IVSþ 1G ! A and 1124G ! A, in the EDAR
gene of a female Japanese patient who showed typical
symptoms of HED. The first sequence variant was a novel
splice-donor-site mutation at 50-end of the intron 2 (Fig 1a).
This mutation was found only in the genomic DNA of the
patient but not her parents (Fig 1c). At the genomic DNA
level, we could not determine whether it had occurred in the
paternal or maternal allele, whereas another mutation,
1124G ! A, was demonstrated to be on the paternal all-
ele (Fig 2b). RT-PCR between the EDAR exons 1 and 3
showed not only normal-sized EDAR transcripts, but short-
er transcripts with skipping of exon 2 (Fig 3a–c). In this
RT-PCR experiment, we did not detect abnormal EDAR tran-
scripts with the inclusion of sequences from intron 2 that is
only 720 bp, in size, indicating the lack of evidence sup-
porting a read-through into intron 2 as consequence of the
splice site mutation. Therefore, we concluded that, in gen-
eral, the exon 2 IVSþ 1G ! A transition destroyed the ‘‘GT-
AG rule’’, leading to the skipping of exon 2. It was strange,
however, that only normal-sized EDAR transcripts with
1124G ! A transition were amplified but aberrant EDAR
transcripts with exon 2 skipping could not be detected
when RT-PCR was performed including downstream from
exon 4 (Fig 3d, e). These results indirectly prove that the
exon 2 IVSþ1G ! A mutation was on the maternal allele
and had occurred in the maternal germline or the patient’s
somatic cells. In addition, the lack of maternal EDAR tran-
scripts in RT-PCR using most primer combinations sug-
gests RNA degradation (Fig 3d, e). This is supported by the
result that, in Fig 3a, the shorter fragment with exon 2 skip-
ping seems to be of lower intensity than the wild-type band,
even though it was not truly a quantitative analysis. So far,
the mechanism for the degradation of the maternal EDAR
transcripts remains to be clarified, but it is certain that, in
our patient, the maternal EDAR gene lacked the ability to
produce functional EDAR protein.
The 1124G ! A transition is a novel point mutation pre-
dicted to result in the substitution of arginine by histidine at
amino acid residue 375 in exon 12 (Fig 2a). This mutation
was shown to have been inherited from the patient’s unaf-
fected father (Fig 2b), indicating that it was a recessive mu-
tation. As described above, RT-PCR analysis showed that
only the paternal EDAR transcripts were detected stably
(Fig 3d, e). Therefore, we reached the conclusion that un-
stable maternal EDAR transcripts caused the loss of het-
erozygosity at the protein level and only the paternal EDAR
proteins containing R375H substitution were generated in
our patient.
EDAR consists of an N-terminal signal pepide, an
extracellular domain, a transmembrane region, and an intra-
cellular domain (Headon and Overbeek, 1999). The extra-
cellular domain of EDAR has been demonstrated to
be crucial for binding to its ligand, EDA-A1 (Yan et al, 2000;
Schneider et al, 2001). In addition, the amino acid residues,
356–431, within the intracellular domain of EDAR shared a
sequence similar to the DD of the TNFR family members
(Headon and Overbeek, 1999). DD is known to play an
important role in downstream signal transduction that in-
duces apoptosis (Hofmann, 1999). Furthermore, receptors
with DD such as TNFR1, Fas, and DR 3-6 have been shown
to interact with cytoplasmic DD adapter proteins (Chin-
naiyan et al, 1995, 1996; Hsu et al, 1995; Chaudhary et al,
Figure 4
Interaction of wild-type or mutant EDAR with EDARADD. HEK293T
cells were co-transfected with a plasmid expressing the N-terminal
Flag-tagged intracellular region of EDAR (EDARIC) together with a
plasmid expressing N-terminal c-myc-tagged EDARADD. Flag-tagged
EDARIC was precipitated with mouse anti-Flag affinity gels (Sigma) and
the binding of c-myc-tagged EDARADD was detected by rabbit anti-c-
myc western blotting (top panel). The expression levels of Flag-tagged
EDARIC (middle panel) and c-myc-tagged EDARADD (bottom panel)
are also shown. Note that wild-type (WT) EDARIC successfully co-pre-
cipitated with EDARADD, whereas R375H mutant EDAR completely
lost this interaction.
Figure 5
The activation of NF-jB by wild-type or mutant EDAR. HEK293T
cells were transfected with 0.1 mg of pNF-kBLuc luciferase reporter
vector (Clontech), 25 ng of pRL-TK vector (Promega), with or without
0.1 mg of each expression construct. The reporter gene activity was
determined with the Dual-Luciferase Reporter Assay System (Prome-
ga). The expression levels of Flag-tagged EDAR are shown at the bot-
tom. Note that R375H mutant EDAR markedly reduced the activation of
NF-kB compared to wild-type EDAR.
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1997; Pan et al, 1998). Recently, the adapter protein of
EDAR has been identified and termed EDARADD (Headon
et al, 2001; Yan et al, 2002). The DD of EDAR has been
shown essential for the interaction with EDARADD because
truncated EDAR without DD lost its affinity to EDARADD
(Headon et al, 2001). EDARADD has been considered to
function as an adapter for EDAR to build an intracellular
signal-transducing complex, leading to the activation of
NF-kB, which contributes to ectodermal morphogenesis
(Headon et al, 2001; Yan et al, 2002). The R375H substi-
tution found in our patient was within the DD of EDAR.
Therefore, we speculated that the R375H substitution of
EDAR would change its affinity to EDARADD, and finally
influence the downstream activation of NF-kB. As expect-
ed, immunoprecipitation demonstrated that the R375H mu-
tant EDAR completely lost its ability to interact with
EDARADD in 293T cells (Fig 4). In addition, the mutant
EDAR markedly reduced the activation of NF-kB compared
with wild-type EDAR in 293T cells that expressed endog-
enous EDARADD (Fig 5). These results strongly indicate that
the R375H mutant EDAR failed to construct an intracellular
signal-transducing complex, leading to the reduced activa-
tion of NF-kB. The R375H is a recessive mutation that does
not cause a dominant-negative effect judged from the ev-
idence that the patient’s unaffected father has this mutation
heterogeneously. Recessive EDAR mutations previously re-
ported in patients with HED were shown to alter the extra-
cellular part of EDAR as opposed to dominant mutations
which were found to affect the intracellular part of the re-
ceptor (Monreal et al, 1999). In our case, however, the amino
acid substitution that affects the intracellular part of the EDAR
molecule is caused by a recessive mutation. Further studies
are needed to reveal the relative functional importance of the
residues mutated in dominant versus recessive HED.
Materials and Methods
Subject A 24-y-old Japanese female visited our hospital because
of decreased sweating with heat intolerance. During her early
childhood, she had experienced recurrent fevers. Her scalp hair
was sparse, with no body hair except for the axilla and genital
areas. Her facial features were notable for sparse eyebrows and
eyelashes, periorbital wrinkling and hyperpigmentation, and a sad-
dle-shaped nose (Fig 6a). She had only two teeth showing a con-
ical crown form (Fig 6b). Her nails were normal, and she had normal
intelligence. Her karyotype was 46XX. Clinical examination con-
firmed that both parents were unaffected, and there was no con-
sanguinity. Her older sister and younger brother had normal clinical
findings. A skin biopsy from her right leg showed no evidence of
hair follicles. In addition, her eccrine sweat glands were hypoplastic.
Source of DNA After informed consent and the approval of the
ethic commission in Niigata University were obtained, peripheral
leukocyte DNA was prepared from the patient, her parents, and
her older sister, using standard protocols. Genomic DNA was
also extracted from 100 unrelated healthy Japanese individuals as
controls.
Analysis of the EDA, EDAR, and EDARADD genes Using the
patient’s DNA, all the exons of the EDA, EDAR, and EDARADD
genes with adjacent sequences of exon–intron borders were am-
plified by PCR. The primers for the EDA gene were designed as
previously reported (Baye´s et al, 1998), and those for the EDAR
and EDARADD genes are indicated in Tables I and II, respectively.
PCR was performed using Advantage 2 DNA polymerase (Clon-
tech, Tokyo, Japan). The amplification conditions for each PCR
reaction were 961C for 3 min, followed by 30 cycles of 961C for
30 s, the indicated annealing temperature for 30 s, and 721C for 1 min,
with a final extension at 721C for 7 min. The amplified PCR frag-
ments were analyzed on 1.5% agarose gels. After gel extraction of
the fragments, direct fluorescent chain-termination DNA cycle
sequencing was performed (Big Dye DNA sequencing kit, Applied
Biosystems, Foster City, CA). The DNA sequences were analyzed
on an ABI373 DNA sequencer (Applied Biosystems).
Screening assays for EDAR mutations In order to analyze the
exon 2 IVSþ 1G ! A mutation in the EDAR gene, allele-specific
PCR was performed. The forward primers used were designed at
the exon 2–intron 2 boundary of the EDAR gene. The point mu-
tation of interest was located at the last base of the 30 end of the
forward primer. These sequences were 50-TGGCTCCCCGTCCT
GGTGG-30 for the wild-type allele, and 50-TGGCTCCCCGTCCT
GGTGA-30 for the mutant allele. The common reverse primer, 50-
TCATGGAGGAGGCGCCCCTG-30, was designed at intron 2 of the
EDAR gene. Each DNA sample (50 ng) from the patient, her family
members, and 100 control individuals was amplified using Advan-
tage 2 DNA polymerase (Clontech). The amplification conditions
were 961C for 3 min, followed by 30 cycles of 961C for 30 s, 681C
for 30 s, and 721C for 1 min, with a final extension at 721C for 7 min.
The amplified fragments were analyzed on 1.5% agarose gels.
1124G ! A substitution in the EDAR gene results in destruction
of the HhaI enzyme site. Exon 12 of the EDAR gene was PCR-
amplified using a forward primer, 50-GTTGACCTTCTATTGACTGT-
Figure6
Clinical appearance of the patient with HED. (a) Her facial features
were notable for a saddle nose, periorbital wrinkling, and hyperpig-
mentation. The hair of the scalp, eyebrows and eyelashes were sparse.
(b) She had oligodontia with only two permanent, conical teeth.
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GAC-30, and a reverse primer, 50-TCAGGGATGCTGTAGCCTGC-30.
The amplification conditions were 961C for 3 min, followed by 30
cycles of 961C for 30 s, 571C for 30 s, and 721C for 1 min, with a
final extension at 721C for 7 min. The amplified fragments were
digested by HhaI restriction enzyme at 371C overnight and analy-
zed on 3.0% agarose gels.
Haplotype analysis Microsatellite genotyping was performed by
PCR amplification of genomic DNA with fluorescent tagged prim-
ers. The primers in the region around the EDAR gene, D2S2216,
D2S2264, D2S293, D2S160, and D2S347, were selected from the
ABI Prism Linkage Mapping Set Version 2.0 (Applied Biosystems).
PCR products were electrophoresed in ABI3100 automated se-
quencers. Microsatellite genotypes were called using GENE MAP-
PER (version 2.0, Applied Biosystems). Haplotypes were manually
constructed for all members of the family examined.
RT-PCR Total RNA was isolated from the skin samples obtained
from biopsies of the patient and a control individual using the Iso-
gen Kit (Nippongene, Tokyo, Japan) according to the manufactur-
er’s recommendations. The RNA was digested for 10 min with
RNase-free DNase (Roche, Mannheim, Germany) in order to re-
move contaminating genomic DNA, and reverse transcribed with a
random primer and the SuperScript II reverse transcriptase (In-
vitrogen, Carlsbad, CA). The cDNAs were amplified by nested PCR
with EDAR-specific primers (Table III) and KOD-Plus DNA polym-
erase (Toyobo, Tokyo, Japan). The first PCR products were purified
using QIAquick PCR Purification Kit (Qiagen GmbH, Hilden, Ger-
many) and 1/50 volume of each product was used for the nested
PCR reaction. The amplification conditions for each PCR reaction
were 941C for 2 min, followed by 30 cycles of 941C for 15 s, the
indicated annealing temperature for 30 s, and 681C for 1 min (2 min
for EDAR exons 1–12 PCR), with a final extension at 681C for 7 min.
GAPDH mRNA was amplified as a control. The PCR products were
analyzed on 1.5% or 3.0% agarose gel and directly sequenced
after gel purification.
Immunoprecipitation The cDNAs encoding the intracellular por-
tion of EDAR (EDARIC; amino acids 212–448) were obtained by
PCR using the cDNAs from both the patient and a control individual
(His and Arg at amino acid position 375, respectively) as templates.
The upstream primer used for the amplification was 50-AAA-
GAATTCGAAGACAAAGCCCTCTGCCCC-30, and the downstream
primer used was 50-AAGATATCTTCAGGATGCAGCATGTGGCTG-
30. They were subcloned in-frame in EcoRI and EcoRV sites of the
pCMV-Tag 2 vector (Stratagene, La Jolla, CA), which expresses
an N-terminal Flag-tagged protein. The resultant plasmids were
designated pCMV-Tag2-EDARIC-375H and pCMV-Tag2-EDARIC-
375R, respectively. The cDNA fragment encoding the full length
EDARADD was amplified by PCR and subcloned into the pCMV-
Tag3 vector (Stratagene) in EcoRI and XhoI sites. The upstream
primer used for the amplification was 50-AAAGAATTCCATGG
GCCTCAGGACGACTA-30, and the downstream primer used was
50-AAACTCGAGTCTAGAAGTGCCTGGAGGGG-30. This was des-
ignated pCMV-Tag3-EDARADD. This vector expresses an N-ter-
minal c-myc-tagged protein.
HEK293T cells grown in six-well plates were transfected using
Lipofectamine 2000 (Invitrogen) with 0.5 mg of either pCMV-Tag2-
EDARIC-375H or pCMV-Tag2-EDARIC-375R, and 0.5 mg of pCMV-
Tag3-EDARADD. Whole-cell extracts were prepared 24 h after
transfection by adding 600 mL of lysis buffer (50 mM HEPES, 150
mM NaCl, 0.5% NP-40, proteinase inhibitors) as previously de-
scribed (Headon et al, 2001). The cell lysates were incubated at
41C overnight by adding 40 mL of mouse anti-Flag M2 affinity gel
(Sigma Chemical, St Louis, MO). The affinity gels were washed
with the lysis buffer five times, re-suspended in 2  SDS sample
buffer (100 mM Tris-HCl [pH 6.8], 4% SDS, 20% glycerol, 12% b-
mercaptoethanol, 0.04% bromophenol blue), and fractionated by
Table I. Primer pairs used for the ampliﬁcation of the EDAR gene
Exon Forward primer (50 ! 30) Reverse primer (50 ! 30) Product size (bp) Annealing temperature (1C)
1 cctctagatggagcaggtgag tctcggccacagctgaagag 376 55
2 ggggttaaataaaggtagccaga gggactatgatcagcattccc 248 60
3–4 ttggggtcttgcaggagtcac ccttgcccgtagcccctcg 1186 63
5 gctctctgcaccagtccctg acaccctctgtagtgaaaggg 229 55
6 ctttgaaggtggagcttctc cctctcctcttctgagctttc 232 60
7–9 cggagtcctggagggaagac ttcactcggctgcaccctgg 767 63
10 ccacaggagaacttgtcaggg agtccttgcggctgtgaggg 293 60
11 gacatggaggatttgcctcctt agttcccctcacaggagctca 224 55
12 gttgaccttctattgactgtgac agctccagagccctcgttgg 443 60
Table II. Primer pairs used for the ampliﬁcation of the EDARADD gene
Exon Forward primer (50 ! 30) Reverse primer (50 ! 30) Product size (bp) Annealing temperature (1C)
1 tctcgcaatctgttgcttcttccat ctctgccttcacacataagaacag 286 60
2 gacttttcatccccgtggtccc gactccgggtctggcgcctg 280 65
3 agtaaggttttcttcagcctaagtaa gcaaaacaataattatcaccattagtgta 229 58
4 gtcataactttcccaagacaaagc tcacgagctaatctatgggcatg 256 60
5 ggcagcatgtgacactgaacc ctaccttactgggatgcttagag 321 58
6 catttggatatgattttaatgaaggttg tcgaccctggcctcaaattatc 166 60
7 gtttctccctgcagagatcagc tttcaacatccggagaggccaa 438 60
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SDS-polyacrylamide gel electrophoresis. For Western blotting, the
gel was transferred to a nitrocellulose filter. The membrane was
incubated with 1:500 dilution of rabbit anti-c-myc primary antibody
(Sigma) and 1:2000 dilution of peroxidase-coupled anti-rabbit sec-
ondary antibody (Dako, Glostrup, Denmark), which was detected
by the enhanced chemiluminescence method (Amersham Pharma-
cia Biotech, Bucks, UK).
NF-jB reporter assay cDNAs encoding full-length EDAR from
both the patient (375H) and a control individual (375R) were sub-
cloned in EcoRI and EcoRV sites of pCMV-Tag2 vector in the
manner described above. These were designated as pCMV-Tag2-
EDAR-375H and pCMV-Tag2-EDAR-375R, respectively.
HEK293T cells were seeded in a six-well plate and transfected
using Lipofectamine 2000 (Invitrogen) with 0.1 mg of pNF-kBLuc
luciferase reporter vector (Clontech), 25 ng of pRL-TK vector
(Promega, Madison, WI), with or without 0.1 mg of each pCMV-
Tag2-EDAR vector. The total amount of transfected DNA was
maintained at 1.0 mg by adding an empty pCMV-Tag2 vector. The
cells in each well were lysed 24 h after transfection and luciferase
activities were measured using a luminometer and the Dual-Lucif-
erase Assay System (Promega). Each transfection was performed
five times.
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Table III. Primer pairs used for RT-PCR ampliﬁcation of the EDAR transcripts
Forward primer (50 ! 30) Reverse primer (50 ! 30)
Product
size (bp)
Annealing
temperature (1C)
Exons 1–3
Primary PCR E1F1:gtcacccagaactggatggtac E3R1:caggtagggctcctctcccg 219 60
Nested PCR E1F2:ctgactttcttcatagacccatct E3R2:cactcctggcacagccccgta 55
Exons 1–4
Primary PCR E1F1 E4R1:gggccacactcagcgtcattctcca 397 60
Nested PCR E1F2 E4R2:gtcccctggtgtcagcacggtgg 55
Exons 1–12
Primary PCR E1F1 E12R1:gctccttggcttgtcctggga 1448 60
Nested PCR E1F2 E12R2:ggacagcccacaggcatgct 55
Exons 11–12
Primary PCR E11F1:ggaaaaagatcctcgatgtgtatgcc E12R1
375
63
Nested PCR E11F2:aacgtgtgtggagtcgtggaag E12R2 63
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